4DMedical Enters Three-Year Commercial Deal With SimonMed Imaging; Shares Surge 11%

MT Newswires Live

May 29

4DMedical (ASX:4DX) struck a three-year commercial deal with US medical imaging provider SimonMed Imaging covering the use of its advanced quantitative cardiopulmonary analysis technology, according to a Friday filing with the Australian bourse.

SimonMed will deploy 4DMedical's CT:VQ and LDAf technology to support clinical decision making for pulmonary assessment at pricing that is based on 4DMedical's per-scan rates, per the filing.

"While the agreement is not immediately financially material, the deployment with SimonMed represents a clear commercial win for 4DMedical, and a material long-term opportunity," the company said.

The deal with SimonMed, which operates more than 170 outpatient imaging centers in the US, represents CT:VQ's entry into the country's outpatient market.

4DMedical shares surged 11% in recent Friday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2639648374"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2639648374\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2639648374?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-29 09:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2639648374","market":"nz","top_or_hot":-1,"title":"4DMedical Enters Three-Year Commercial Deal With SimonMed Imaging; Shares Surge 11%","media":"MT Newswires Live","content":"<html><body><p> 4DMedical (ASX:4DX) struck a three-year commercial deal with US medical imaging provider SimonMed Imaging covering the use of its advanced quantitative cardiopulmonary analysis technology, according to a Friday filing with the Australian bourse.</p><p>SimonMed will deploy 4DMedical's CT:VQ and LDAf technology to support clinical decision making for pulmonary assessment at pricing that is based on 4DMedical's per-scan rates, per the filing.</p><p>\"While the agreement is not immediately financially material, the deployment with SimonMed represents a clear commercial win for 4DMedical, and a material long-term opportunity,\" the company said.</p><p>The deal with SimonMed, which operates more than 170 outpatient imaging centers in the US, represents CT:VQ's entry into the country's outpatient market.</p><p>4DMedical shares surged 11% in recent Friday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4DMedical Enters Three-Year Commercial Deal With SimonMed Imaging; Shares Surge 11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4DMedical Enters Three-Year Commercial Deal With SimonMed Imaging; Shares Surge 11%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-05-29 09:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> 4DMedical (ASX:4DX) struck a three-year commercial deal with US medical imaging provider SimonMed Imaging covering the use of its advanced quantitative cardiopulmonary analysis technology, according to a Friday filing with the Australian bourse.</p><p>SimonMed will deploy 4DMedical's CT:VQ and LDAf technology to support clinical decision making for pulmonary assessment at pricing that is based on 4DMedical's per-scan rates, per the filing.</p><p>\"While the agreement is not immediately financially material, the deployment with SimonMed represents a clear commercial win for 4DMedical, and a material long-term opportunity,\" the company said.</p><p>The deal with SimonMed, which operates more than 170 outpatient imaging centers in the US, represents CT:VQ's entry into the country's outpatient market.</p><p>4DMedical shares surged 11% in recent Friday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7094","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2639648374","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2639648374","pubTimestamp":1780018807,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"4DMedical  struck a three-year commercial deal with US medical imaging provider SimonMed Imaging covering the use of its advanced quantitative cardiopulmonary analysis technology, according to a Friday filing with the Australian bourse.SimonMed will deploy 4DMedical's CT:VQ and LDAf technology to support clinical decision making for pulmonary assessment at pricing that is based on 4DMedical's per-scan rates, per the filing.\"While the agreement is not immediately financially material, the deployment with SimonMed represents a clear commercial win for 4DMedical, and a material long-term opportunity,\" the company said.The deal with SimonMed, which operates more than 170 outpatient imaging centers in the US, represents CT:VQ's entry into the country's outpatient market.4DMedical shares surged 11% in recent Friday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7094":"医疗保健技术","4DX.AU":"4DMEDICAL LTD"},"translate_title":"4DMedical与SimonMed Imaging达成为期三年的商业协议；股价飙升11%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"4DX.AU":1},"content_text":"4DMedical (ASX:4DX) struck a three-year commercial deal with US medical imaging provider SimonMed Imaging covering the use of its advanced quantitative cardiopulmonary analysis technology, according to a Friday filing with the Australian bourse.SimonMed will deploy 4DMedical's CT:VQ and LDAf technology to support clinical decision making for pulmonary assessment at pricing that is based on 4DMedical's per-scan rates, per the filing.\"While the agreement is not immediately financially material, the deployment with SimonMed represents a clear commercial win for 4DMedical, and a material long-term opportunity,\" the company said.The deal with SimonMed, which operates more than 170 outpatient imaging centers in the US, represents CT:VQ's entry into the country's outpatient market.4DMedical shares surged 11% in recent Friday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}